cardiooncologyfacts: How do we assess risk and guide therapy for Atrial Fibrillation? The CHA2DS2-VASC score has supplanted the CHADS2 score as the standard risk assessment tool (Class I evidence) in the 2014 AHA/ACC Guideline for Management of Patients